GlassScriptPhysician profile
Mindy L Shaffran
NPI 1922084383
$20,384.84
in general payments reported to CMS, 2019-2025
15 companies · $363 in 2025
The $363 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $19K · 2020: $41.76 · 2021: $66.36 · 2022: $134 · 2023: $261 · 2024: $143 · 2025: $363.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $767.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $767.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lupin INC. | $19,107.00 | 2019 | |
| Abbvie INC. | $325.21 | 2019-2025 | |
| Amgen INC. | $187.33 | 2020-2025 | Evenity, Prolia |
| Daiichi Sankyo INC. | $154.50 | 2023-2025 | Injectafer |
| Mayne Pharma Commercial LLC | $144.73 | 2022-2025 | |
| Astellas Pharma US INC | $137.04 | 2023-2025 | Veozah |
| Bayer Healthcare Pharmaceuticals INC. | $94.62 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $38.50 | 2021 | |
| Idorsia Pharmaceuticals US INC | $35.00 | 2023 | Quviviq |
| Organon LLC | $29.93 | 2022-2023 | Nexplanon |
| Thd America, INC. | $28.42 | 2025 | |
| Coopersurgical, INC. | $27.86 | 2021 | |
| Pfizer INC. | $25.41 | 2025 | |
| Sumitomo Pharma America, INC. | $24.85 | 2025 | Myfembree |
| Myovant Sciences INC. | $24.44 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mindy Shaffran listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.